DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance
2016 · Oncotarget · 65 citations
https://doi.org/10.18632/oncotarget.6910
D
Dominik P. Elmer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
16
Papers
390
Citations
8
h-index
7
i10-index
Dominik P. Elmer is an academic researcher from University of Salzburg. The author has contributed to research in topics: Hedgehog Signaling Pathway Studies & Epigenetics and DNA Methylation & Cancer-related Molecular Pathways. The author has an h-index of 8, co-authored 14 publications.
ORCID: 0000-0003-2038-6775Papers by this author
worksTargeting class <scp>I</scp> histone deacetylases by the novel small molecule inhibitor 4<scp>SC</scp>‐202 blocks oncogenic hedgehog‐<scp>GLI</scp> signaling and overcomes smoothened inhibitor resistance
2017 · International Journal of Cancer · 51 citations
https://doi.org/10.1002/ijc.31117
Targeting NLRP3 inhibits AML progression by inducing PERK/eIF2-mediated apoptosis
2024 · Cell Communication and Signaling · 8 citations
https://doi.org/10.1186/s12964-024-01777-6
Cooperative Hedgehog/GLI and JAK/STAT signaling drives immunosuppressive tryptophan/kynurenine metabolism via synergistic induction of IDO1 in skin cancer
2025 · Cell Communication and Signaling · 6 citations
https://doi.org/10.1186/s12964-025-02101-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat